Published in J Urol on November 01, 1983
Acupuncture assisted local anesthesia for penile surgeries. Transl Androl Urol (2013) 0.76
Does tunica anatomy matter in penile implant? Transl Androl Urol (2015) 0.76
Venous ligation: a novel strategy for glans enhancement in penile prosthesis implantation. Biomed Res Int (2014) 0.75
Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc (1988) 6.41
Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol (1994) 2.10
Percutaneous removal of kidney stones: review of 1,000 cases. J Urol (1985) 2.04
Cellular autofluorescence--is it due to flavins? J Histochem Cytochem (1979) 1.99
The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974. Mayo Clin Proc (1977) 1.95
Fluorescence properties of indocyanine green as related to angiography. Phys Med Biol (1978) 1.82
Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol (1994) 1.75
Mayo Clinic long-term analysis of the functional durability of the AMS 800 artificial urinary sphincter: a review of 323 cases. J Urol (1998) 1.66
Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA (1984) 1.65
Rupture of the pregnant uterus: a review. Obstet Gynecol Surv (1978) 1.59
Ureteroscopy: current practice and long-term complications. J Urol (1997) 1.56
Impact of endourology on diagnosis and management of upper urinary tract urothelial cancer. J Urol (1989) 1.55
Fetal heart rate as a predictor of fetal distress. A report from the collaborative project. Obstet Gynecol (1968) 1.51
High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol (2000) 1.44
Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am J Med (1974) 1.42
A prospective randomized comparison of epidural infusion of fentanyl and intravenous administration of morphine by patient-controlled analgesia after radical retropubic prostatectomy. Mayo Clin Proc (1992) 1.40
Visual laser ablation of the prostate: a preliminary report. Mayo Clin Proc (1995) 1.40
Long-term followup and evaluation of primary realignment of posterior urethral disruptions. J Urol (1997) 1.40
Retroperitoneal approach for aortic surgery: is it worth it? Cardiovasc Surg (2001) 1.39
Transurethral microwave thermotherapy for prostatism: early Mayo Foundation experience. Mayo Clin Proc (1992) 1.39
Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden. Am J Clin Pathol (1996) 1.39
Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism. J Clin Invest (1974) 1.30
High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology (1998) 1.28
Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol (1995) 1.28
Percutaneous antegrade endopyelotomy: review of 50 consecutive cases. J Urol (1995) 1.27
Carcinoma of the seminal vesicle. J Urol (1984) 1.24
Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol (2000) 1.17
The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J Urol (1991) 1.17
Recent advances in comparative molecular field analysis (CoMFA). Prog Clin Biol Res (1989) 1.17
Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer (1988) 1.16
Comparison of techniques for vesicourethral anastomosis: simple direct versus modified Vest traction sutures. Urology (1988) 1.13
Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis. Arthritis Rheum (1988) 1.13
Acute panautonomic neuropathy. Ann Neurol (1983) 1.11
Extracorporeal shock-wave lithotripsy and methyl tert-butyl ether for partially calcified gallstones. Gastroenterology (1989) 1.08
Cancer-to-cancer metastasis. J Urol (1984) 1.07
Indwelling ureteral stents: percutaneous management of complications. Radiology (1986) 1.06
High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology (1997) 1.06
A case of pediatric ureteroscopic lasertripsy. J Urol (1988) 1.05
Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology (1996) 1.04
Natural history of prostatism: urinary flow rates in a community-based study. J Urol (1993) 1.04
Relationship of leukoplakia to urothelial malignancy. J Urol (1984) 1.03
A randomized crossover study using yohimbine and isoxsuprine versus pentoxifylline in the management of vasculogenic impotence. J Urol (1996) 1.03
Colorimetric method for the determination of lipoxygenase activity. J Agric Food Chem (2001) 1.02
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology (1996) 1.01
Improvement of pressure flow parameters with finasteride is greater in men with large prostates. Finasteride Urodynamics Study Group. J Urol (1999) 1.01
Cryptorchism and maternal estrogen exposure. Am J Epidemiol (1984) 1.00
Deoxycytidylate and deoxyguanylate kinase activity in pneumococci after exposure to known polyribonucleotides. Science (1967) 1.00
Artificial urinary sphincter cuff erosion. Experience with reimplantation in 38 patients. Urology (1990) 1.00
Effects of polyribonucleotides of known composition on deoxycytidylate and deoxyguanylate kinase activity in Pneumococci. J Biol Chem (1968) 0.99
Renal cell carcinoma in von Hippel-Lindau syndrome. Am J Med (1987) 0.98
Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma. Urology (1996) 0.97
Colon perforation following percutaneous nephrostomy and renal calculus removal. Radiology (1985) 0.97
Giant leiomyoma of the prostate. Arch Pathol Lab Med (1987) 0.96
Treatment of diffuse transitional cell carcinoma in situ by whole bladder hematoporphyrin derivative photodynamic therapy. J Urol (1985) 0.96
Endoscopic management of bladder cancer with hematoporphyrin derivative phototherapy. Urol Clin North Am (1984) 0.96
Extended resection for locally advanced primary adenocarcinoma of the rectum. Dis Colon Rectum (1989) 0.95
Fetal compromise during elective cesarean section. II. A report from the Colloborative Project. Am J Obstet Gynecol (1969) 0.95
Transitional cell carcinoma of the bladder in children and adolescents. J Urol (1983) 0.95
Repeated pressure-flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement. Finasteride Urodynamics Study Group. Neurourol Urodyn (1999) 0.95
Success of de novo reimplantation of the artificial genitourinary sphincter. J Urol (2000) 0.94
Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res (2002) 0.93
Percutaneous removal of kidney stones. Preliminary report. Mayo Clin Proc (1982) 0.92
Estramustine phosphate compared with diethylstilbestrol. A randomized, double-blind, crossover trial for stage D prostate cancer. Am J Clin Oncol (1986) 0.92
The artificial urinary sphincter in the female: indications for use, surgical approach and results. Int Urogynecol J Pelvic Floor Dysfunct (1998) 0.92
Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy. J Urol (1983) 0.92
Percutaneous lithotripsy. J Urol (1983) 0.91
Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors. Cancer (1992) 0.91
Flow evaluation and simultaneous external sphincter electromyography in clinical urodynamics. J Urol (1981) 0.91
Stented versus nonstented ureteroileal anastomoses: is there a difference with regard to leak and stricture? J Urol (1985) 0.91
Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy. J Urol (1987) 0.91
Testicular adnexal fibrous pseudotumors. Urology (1984) 0.90
Ureteroscopy. J Urol (1988) 0.90
The etiology and treatment of delayed bleeding following percutaneous lithotripsy. J Urol (1985) 0.90
Prediction of stone composition from plain radiographs: a prospective study. J Endourol (1999) 0.90
Observations on vesical diverticulum in childhood. J Urol (1976) 0.90
Detection and localization of In situ carcinoma of the bladder with hematoporphyrin derivative. Mayo Clin Proc (1982) 0.90
Artificial urethral sphincter for incontinence. Urology (2000) 0.90
Recurrent or persistent urinary incontinence in patients with the artificial urinary sphincter: diagnostic considerations and management. J Urol (1985) 0.89
Neodymium:YAG laser treatment of cystitis glandularis. J Urol (1988) 0.89
Preoperative magnetic resonance imaging of vena caval tumor thrombi: experience with 5 cases. J Urol (1987) 0.89
The model AS 800 artificial urinary sphincter: Mayo Clinic experience. J Urol (1987) 0.89
Strategies for ureteral catheterization after antireflux surgery by the Cohen technique of transverse advancement. J Urol (1991) 0.88
The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study. J Urol (1981) 0.87
Visualizing substructural fingerprints. J Mol Graph Model (2000) 0.87
An implantable mechanical urinary sphincter: a new nonhydraulic design concept. Urology (1998) 0.86
An automated, handheld biosensor for aflatoxin. Biosens Bioelectron (2000) 0.86
Mayo Clinic experience with use of the AMS800 artificial urinary sphincter for urinary incontinence following radical prostatectomy. J Urol (1989) 0.86
Use of the artificial urinary sphincter in the management of severe incontinence in females. Surg Gynecol Obstet (1985) 0.86
Mayo Clinic experience with the AS800 artificial urinary sphincter for urinary incontinence after transurethral resection of prostate or open prostatectomy. Urology (1993) 0.85
Primary realignment of posterior urethral injuries. J Urol (1983) 0.85